In 2010, the provinces and territories announced the creation the Pan-Canadian Pricing Alliance (“PCPA”). The PCPA is an initiative aimed at joint negotiations on..
March 25, 2014
On March 14, 2014, the Court of Appeal released two decisions with respect to proceedings commenced pursuant to section 8 of the Patented Medicines Regulations.
March 24, 2014
Over the past year, there were a number of notable developments in matters relating to branding and naming of pharmaceutical products in Canada.
March 17, 2014
This case concerns a proposed generic version of the brand name drug PATADAY, an eye drop solution used to treat allergic and inflammatory eye reactions.
Many of the provisions of Canada’s law governing commercial electronic messages (CEMs) will come into effect on July 1, 2014.
February 19, 2014
There have been a number of developments in biosimilars of late, including regulatory approvals in Canada issued on January 15, 2014 for two biosimilar products,...
January 23, 2014
The Federal Court has issued the first decision in Canada addressing the alleged infringement and validity of humanized antibody claims.
January 20, 2014
This was an application for judicial review of a decision made by the Therapeutic Products Directorate (“TPD”) at Health Canada that addressed the meaning of the...
January 13, 2014
This decision provides new insight into the construction of the hypothetical market in which generic damages are assessed.
December 18, 2013
Continuing a line of cases dealing with access to information surrounding dealings between government and pharmaceutical manufacturers, in two decisions released...
December 16, 2013
Try searching our global site instead